Literature DB >> 21131312

Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins.

Heta Merikallio1, Riitta Kaarteenaho, Paavo Pääkkö, Siri Lehtonen, Pasi Hirvikoski, Riitta Mäkitaro, Terttu Harju, Ylermi Soini.   

Abstract

BACKGROUND: Zeb1 and twist regulate expression of genes which take part in epitheliomesenchymal transition (EMT). Claudins are tight junctional proteins regulating polarity and paracellular permeability of epithelial cells. AIMS AND METHODS: To study Zeb1 and twist in 289 primary and 54 metastatic lung tumours and their relation to expression of claudins 1-5 and 7 by immunohistochemistry.
RESULTS: Metastatic tumours showed a significantly lower expression of zeb1 and twist (33.0% and 38.0% vs 5.0% and 14.5%, p<0.001 for both) and they also had a significantly lower expression of claudin 1 (p<0.001), claudin 4 (p<0.001), claudin 5 (p=0.001) and claudin 7 (p<0.001) than did primary tumours. Primary lung tumours showed a strong inverse association between zeb1 and claudin 1 (p=0.024) and claudin 2 (p=0.003). For twist an inverse association was found with claudin 5 (p=0.007). In metastatic tumours zeb1 was inversely associated with claudin 7 (p=0.050) and twist with claudin 5 (p=0.025). Overexpression of claudin 5 was associated with decreased survival (p=0.017). For zeb1 or twist, no association with survival was observed in primary or metastatic tumours.
CONCLUSIONS: According to protein expression, involvement of zeb1 and twist in EMT in primary lung tumours is relatively infrequent. Carcinomas metastatic to the lung showed a significantly higher expression of these transcriptional factors than primary lung tumours, indicating their probable importance in the metastatic process. Zeb1 and twist were inversely associated with several claudins, indicating a role in their down-regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131312     DOI: 10.1136/jcp.2010.086678

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

Review 1.  Tight junctions in lung cancer and lung metastasis: a review.

Authors:  Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.

Authors:  Juanjuan Che; Yifan Yang; Jing Xiao; Pengfei Zhao; Bo Yan; Shuo Dong; Bangwei Cao
Journal:  Tumour Biol       Date:  2015-03-28

3.  TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.

Authors:  Marko Stankic; Svetlana Pavlovic; Yvette Chin; Edi Brogi; David Padua; Larry Norton; Joan Massagué; Robert Benezra
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

4.  Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.

Authors:  Ágnes Holczbauer; Benedek Gyöngyösi; Gábor Lotz; Attila Szijártó; Péter Kupcsulik; Zsuzsa Schaff; András Kiss
Journal:  J Histochem Cytochem       Date:  2013-02-05       Impact factor: 2.479

Review 5.  Twist: a molecular target in cancer therapeutics.

Authors:  Md Asaduzzaman Khan; Han-chun Chen; Dianzheng Zhang; Junjiang Fu
Journal:  Tumour Biol       Date:  2013-07-20

Review 6.  The role of TWIST1 in epithelial-mesenchymal transition and cancers.

Authors:  Qing-Qing Zhu; Chenhui Ma; Qian Wang; Yong Song; Tangfeng Lv
Journal:  Tumour Biol       Date:  2015-11-24

7.  SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.

Authors:  A Barbáchano; A Fernández-Barral; F Pereira; M F Segura; P Ordóñez-Morán; E Carrillo-de Santa Pau; J M González-Sancho; D Hanniford; N Martínez; A Costales-Carrera; F X Real; H G Pálmer; J M Rojas; E Hernando; A Muñoz
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

Review 8.  Claudins in lung diseases.

Authors:  Ylermi Soini
Journal:  Respir Res       Date:  2011-05-27

9.  TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain.

Authors:  Young Suk Jung; Xu-Wen Liu; Rosemarie Chirco; Richard B Warner; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

Review 10.  Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.

Authors:  Xun Yuan; Hua Wu; Na Han; Hanxiao Xu; Qian Chu; Shiying Yu; Yuan Chen; Kongming Wu
Journal:  J Hematol Oncol       Date:  2014-12-05       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.